PET and SPECT Exploration of Central Monoaminergic Transporters for the Development of New Drugs and Treatments in Brain Disorders

By  

Current Pharmaceutical Design, Vol. 11, Iss. 25, 2005-10 ,pp. : 3237-3245

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Strategies to Predict Effect of P-Glycoprotein Transporter Efflux and Minimize its Impact on the Penetration of Drugs into the Central Nervous System (CNS)

By  

Current Computer - Aided Drug Design, Vol. 4, Iss. 1, 2008-03 ,pp. : 67-75

Bentham Science Publishers

Access to resources Recommend Favorite

Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine

By Suzuki H.   Sugiyama Y.  

European Journal of Pharmaceutical Sciences, Vol. 12, Iss. 1, 2000-11 ,pp. : 3-12

Elsevier

Access to resources Recommend Favorite

Neurogenic Drugs and Compounds to Treat CNS Diseases and Disorders

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 1, 2011-01 ,pp. : 35-37

Bentham Science Publishers

Access to resources Recommend Favorite

Role of CNS Transporters in the Pharmacotherapy of HIV-1 Associated Neurological Disorders

By  

Current Pharmaceutical Design, Vol. 20, Iss. 10, 2014-03 ,pp. : 1543-1563

Bentham Science Publishers

Access to resources Recommend Favorite